Dana-Farber Cancer Institute Presidential Symposium 2022

Laurie H. Glimcher, MD
President and CEO, Dana-Farber Cancer Institute
Richard and Susan Smith Professor of Medicine, Harvard Medical School

José Vicente Aguerrevere
Trustee, Advocate, and Supporter, Dana-Farber Cancer Institute

Josh Bekenstein
Chairman, Dana-Farber’s Board of Trustees
Managing Director and Co-Chairman, Bain Capital LP

Ben Ebert, MD, PhD
Chair of Medical Oncology, Dana-Farber Cancer Institute
Investigator, Howard Hughes Medical Institute
George P. Canellos, MD and Jean S. Canellos Professor of Medicine, Harvard Medical School

Levi Garraway, MD, PhD
Executive Vice President, Head of Global Product Development and Chief Medical Officer, Roche and Genentech

Irene Ghobrial, MD
Director, Center of Prevention of Progression of Blood Cancers
Director, Clinical Investigator Research Program
Director, Translational Research in Multiple Myeloma Program, Dana-Farber Cancer Institute
Lavine Family Chair for Preventative Cancer Therapies at Dana-Farber
Co-Director, Lymphoma and Myeloma Program, Dana-Farber/Harvard Cancer Center

Cigall Kadoch, PhD
Principal Investigator, Pediatric Oncology, Dana-Farber Cancer Institute
Co-Director, Epigenomics Program, Broad Institute of MIT and Harvard

William G. Kaelin Jr., MD
Researcher, Dana-Farber Cancer Institute
Investigator, Howard Hughes Medical Institute
Sidney Farber Professor of Medicine, Harvard Medical School
Nobel Laureate, 2019 Nobel Prize in Medicine

Ann LaCasce, MD, MMSc
Director, Dana-Farber/Mass General Brigham Fellowship in Hematology/Oncology
Fellowship Program in Hematology/Oncology Chair at Dana-Farber

Tom Lynch, MD
President & Director, Fred Hutchinson Cancer Center

Robert J. Mayer, MD
Faculty Vice President for Academic Affairs
Stephen B. Kay Family Professor of Medicine, Harvard Medical School

Nadine Jackson McCleary, MD, MPH
Medical Director, Patient Reported Data Program
Medical Oncologist, Gastrointestinal Cancer Center
Leader, Inclusion, Diversity, & Equity Clinical Trial Access Committee, Dana-Farber Cancer Institute

Barrett J. Rollins, MD, PhD
Chief Scientific Officer, Emeritus, Dana-Farber Cancer Institute
Linde Family Professor of Medicine, Harvard Medical School

Norman E. "Ned" Sharpless, MD
Former Director of the National Cancer Institute

Chuck Stravin
Patient Perspective

Sapna Syngal, MD, MPH
Director of Research, Center for Cancer Genetics and Prevention
Director, Gastrointestinal Cancer Genetics and Prevention Clinics
Founder, Lynch Syndrome Center, Dana-Farber Cancer Institute

Victoria Warren
Event Emcee
Media Relations Manager, Dana-Farber Cancer Institute
Former Reporter, WHDH 7 News Boston

Lachelle Weeks, MD, PhD
Physician, Center for Leukemia and Center for Prevention of Progression, Division of Hematologic Malignancies, Dana-Farber Cancer Institute

Presidential Symposium

Dana-Farber Cancer Institute Presidential Symposium

Overcoming Cancer's Biggest Challenges, Together

Meet Our Speakers

Presidential Symposium

Dana-Farber Cancer Institute Presidential Symposium Overcoming Cancer's Biggest Challenges, Together

Meet Our Speakers

Dana-Farber Cancer Institute Presidential Symposium

Overcoming Cancer's Biggest Challenges, Together